Genesis Healthcare (GEN) Issues Earnings Results

Genesis Healthcare (NYSE:GEN) announced its earnings results on Wednesday. The company reported ($0.57) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.32) by ($0.25), RTT News reports. The business had revenue of $1.22 billion during the quarter, compared to the consensus estimate of $1.21 billion. During the same quarter last year, the firm posted ($0.34) earnings per share.

Shares of NYSE:GEN traded up $0.01 during trading on Thursday, hitting $1.69. The company’s stock had a trading volume of 397,876 shares, compared to its average volume of 638,504. The company has a market cap of $266.53 million, a price-to-earnings ratio of -0.80 and a beta of 0.50. Genesis Healthcare has a fifty-two week low of $0.60 and a fifty-two week high of $2.86.

In other Genesis Healthcare news, Director David A. Reis sold 19,456 shares of the business’s stock in a transaction on Friday, November 2nd. The shares were sold at an average price of $1.64, for a total value of $31,907.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In the last 90 days, insiders sold 316,749 shares of company stock valued at $538,569. Insiders own 58.10% of the company’s stock.

GEN has been the topic of a number of research analyst reports. ValuEngine lowered Genesis Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, July 18th. Cantor Fitzgerald restated a “buy” rating and issued a $7.00 price target on shares of Genesis Healthcare in a research note on Wednesday, October 3rd. Finally, Credit Suisse Group began coverage on shares of Genesis Healthcare in a research note on Tuesday, October 16th. They issued a “neutral” rating and a $1.75 price target for the company. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $3.19.

COPYRIGHT VIOLATION NOTICE: This story was reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at

Genesis Healthcare Company Profile

Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.

Featured Article: What does RSI mean?

Earnings History for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with's FREE daily email newsletter.

Leave a Reply